市場調査レポート

商品コード

1754047

カテーテル指向性血栓溶解療法の市場レポート：送達モード、適応症、エンドユーザー、地域別、2025年～2033年

Catheter-Directed Thrombolysis Devices Market Report by Delivery Mode, Indication (Pulmonary Embolism, Deep Vein Thrombosis, Stroke, and Others), End User, and Region 2025-2033

出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 142 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF & Excel (Single User License)

USD 2,999 437,254円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcelの印刷は一度のみ可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (5 User License)

USD 3,999 583,054円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcelの印刷は可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,999 728,854円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等の編集は可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=145.80円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

カテーテル指向性血栓溶解療法の世界市場規模は2024年に3億9,440万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに5億9,160万米ドルに達し、2025年から2033年にかけて4.61%の成長率（CAGR）を示すと予測しています。慢性疾患の有病率の増加、肺塞栓症の早期発見・早期治療の重要性に対する消費者の意識の高まり、ヘルスケアインフラの大幅な改善などが、市場を後押しする主な要因のひとつです。

カテーテル指向性血栓溶解療法は、体内の血管内に形成される血栓を治療するために使用される高度な医療機器です。これらの器具は、血栓溶解剤を血栓部位に直接送達するよう特別に設計されており、閉塞を溶解して血流を回復させる働きをします。この治療法では、X線や超音波などの画像誘導下で、カテーテルという細くて柔軟な管を患部の血管に挿入します。カテーテルを通して血栓溶解薬が血栓に直接投与されるか、血栓を取り囲む血管に注入されます。カテーテル直接血栓溶解療法は、血流を速やかに回復させ、長期的な合併症のリスクを軽減し、罹患した臓器や手足の機能を維持する上で非常に有効であることが証明されています。深部静脈血栓症（DVT）、肺塞栓症、末梢動脈閉塞症、その他の血管障害などの治療によく用いられます。

北米
- 米国
- カナダ
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- 残りの欧州
アジア太平洋地域
- 中国
- インド
- 日本
- オーストラリア
- 韓国
- インドネシア
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- メキシコ
- 残りのラテンアメリカ
中東・アフリカ
- 市場内訳：国別

第10章 SWOT分析

概要
強み
弱み
機会
脅威

第11章バリューチェーン分析

第12章ポーターのファイブフォース分析

概要
買い手の交渉力
供給企業の交渉力
競合の程度
新規参入業者の脅威
代替品の脅威

第13章価格分析

第14章競合情勢

市場構造
主要企業
主要企業のプロファイル
- AngioDynamics, Inc
- Boston Scientific Corporation
- Inari Medical, Inc.
- iVascular, S.L.U
- Medtronic Plc
- Penumbra, Inc.
- Straub Medical AG（Becton, Dickinson and Company）
- Teleflex Incorporated
- Thrombolex Inc.

図表

List of Figures

Figure 1: Global: Catheter-Directed Thrombolysis Devices Market: Major Drivers and Challenges
Figure 2: Global: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million USD), 2019-2024
Figure 3: Global: Catheter-Directed Thrombolysis Devices Market: Breakup by Delivery Mode (in %), 2024
Figure 4: Global: Catheter-Directed Thrombolysis Devices Market: Breakup by Indication (in %), 2024
Figure 5: Global: Catheter-Directed Thrombolysis Devices Market: Breakup by End User (in %), 2024
Figure 6: Global: Catheter-Directed Thrombolysis Devices Market: Breakup by Region (in %), 2024
Figure 7: Global: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 8: Global: Catheter-Directed Thrombolysis Devices (Directly delivery to blood clot) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Catheter-Directed Thrombolysis Devices (Directly delivery to blood clot) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Catheter-Directed Thrombolysis Devices (Positioning medical device at clot site) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Catheter-Directed Thrombolysis Devices (Positioning medical device at clot site) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Catheter-Directed Thrombolysis Devices (Pulmonary Embolism-PE) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Catheter-Directed Thrombolysis Devices (Pulmonary Embolism-PE) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Catheter-Directed Thrombolysis Devices (Deep Vein Thrombosis -DVT) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Catheter-Directed Thrombolysis Devices (Deep Vein Thrombosis -DVT) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Catheter-Directed Thrombolysis Devices (Stroke) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Catheter-Directed Thrombolysis Devices (Stroke) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Catheter-Directed Thrombolysis Devices (Other Indications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Catheter-Directed Thrombolysis Devices (Other Indications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Catheter-Directed Thrombolysis Devices (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Catheter-Directed Thrombolysis Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Catheter-Directed Thrombolysis Devices (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Catheter-Directed Thrombolysis Devices (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: North America: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: North America: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: United States: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: United States: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Canada: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Canada: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Europe: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Europe: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Germany: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Germany: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: France: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: France: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: United Kingdom: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: United Kingdom: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Italy: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Italy: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: Spain: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: Spain: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Russia: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Russia: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Rest of Europe: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Rest of Europe: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Asia-Pacific: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Asia-Pacific: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: China: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: China: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: India: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: India: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Japan: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Japan: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Australia: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Australia: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: South Korea: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: South Korea: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Indonesia: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Indonesia: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Rest of Asia-Pacific: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Rest of Asia-Pacific: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Latin America: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Latin America: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Brazil: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Brazil: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Mexico: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Mexico: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Rest of Latin America: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Rest of Latin America: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Middle East and Africa: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Middle East and Africa: Catheter-Directed Thrombolysis Devices Market: Breakup by Country (in %), 2024
Figure 72: Middle East and Africa: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Global: Catheter-Directed Thrombolysis Devices Industry: SWOT Analysis
Figure 74: Global: Catheter-Directed Thrombolysis Devices Industry: Value Chain Analysis
Figure 75: Global: Catheter-Directed Thrombolysis Devices Industry: Porter's Five Forces Analysis
Figure 76: Global: Catheter-Directed Thrombolysis Devices Market: Breakup of Production Cost

List of Tables

Table 1: Global: Catheter-Directed Thrombolysis Devices Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Catheter-Directed Thrombolysis Devices Market: Breakup by Delivery Mode (in Million USD), 2019 & 2024
Table 3: Global: Catheter-Directed Thrombolysis Devices Market Forecast: Breakup by Delivery Mode (in Million USD), 2025-2033
Table 4: Global: Catheter-Directed Thrombolysis Devices Market: Breakup by Indication (in Million USD), 2019 & 2024
Table 5: Global: Catheter-Directed Thrombolysis Devices Market Forecast: Breakup by Indication (in Million USD), 2025-2033
Table 6: Global: Catheter-Directed Thrombolysis Devices Market: Breakup by End User (in Million USD), 2019 & 2024
Table 7: Global: Catheter-Directed Thrombolysis Devices Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 8: Global: Catheter-Directed Thrombolysis Devices Market: Breakup by Region (in Million USD), 2019 & 2024
Table 9: Global: Catheter-Directed Thrombolysis Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 10: Global: Catheter-Directed Thrombolysis Devices Industry: Key Price Indicators
Table 11: Global: Catheter-Directed Thrombolysis Devices Market: Competitive Structure
Table 12: Global: Catheter-Directed Thrombolysis Devices Market: Key Players

Product Code: SR112025A4990

The global catheter-directed thrombolysis devices market size reached USD 394.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 591.6 Million by 2033, exhibiting a growth rate (CAGR) of 4.61% during 2025-2033. The growing prevalence of chronic diseases, the rising consumer awareness about the importance of early detection and treatment of pulmonary embolism, and significant improvements in the healthcare infrastructure are some of the major factors propelling the market.

Catheter-directed thrombolysis devices are advanced medical tools used to treat blood clots that form within the body's blood vessels. These devices are specifically designed to deliver thrombolytic agents directly to the site of the clot, where they work to dissolve the obstruction and restore blood flow. The procedure involves the insertion of a catheter, a thin, flexible tube, into the affected blood vessel under image guidance, such as an X-ray or ultrasound. Through the catheter, a clot-dissolving medication is delivered directly to the clot or infused into the blood vessel surrounding it. Catheter-directed thrombolysis has proven to be highly effective in quickly restoring blood flow, reducing the risk of long-term complications, and preserving the functionality of the affected organ or limb. It is commonly used to treat conditions, such as deep vein thrombosis (DVT), pulmonary embolism, peripheral arterial occlusions, and other vascular disorders.

Catheter-Directed Thrombolysis Devices Industry Segmentation:

Breakup by Delivery Mode:

Directly Delivery to Blood Clot
Positioning Medical Device at Clot Site

Directly delivering thrombolytic agents to the blood clot is a significant delivery mode in catheter-directed thrombolysis. In this approach, the catheter is inserted directly into the blood vessel where the clot is located, ensuring precise and targeted administration of the thrombolytic medication. This method allows for a concentrated and localized action, effectively dissolving the clot and restoring blood flow without affecting other parts of the circulatory system.

On the other hand, the positioning of a medical device at the clot site is a delivery mode in catheter-directed thrombolysis. These devices may include mechanical thrombectomy devices, such as rotating catheters or aspiration systems. This delivery mode is particularly beneficial in cases where direct infusion of thrombolytic agents may not be suitable, such as in large or resistant clots, or when the risk of bleeding from medication is a concern.

Breakup by Indication:

Pulmonary Embolism (PE)
Deep Vein Thrombosis (DVT)
Stroke
Others

Pulmonary embolism is a critical medical condition and a leading indication segment in the catheter-directed thrombolysis market. PE occurs when a blood clot, often originating from deep veins in the legs, travels through the bloodstream and lodges in the arteries of the lungs, causing a potentially life-threatening obstruction. Catheter-directed thrombolysis is a highly effective treatment for PE as it rapidly dissolves the clot and restores blood flow to the lungs.

On the other hand, deep vein thrombosis is another major indication segment in the catheter-directed thrombolysis market. DVT occurs when a blood clot forms in a deep vein, most commonly in the legs. Catheter-directed thrombolysis for DVT not only alleviates symptoms and reduces the risk of severe complications but also plays a crucial role in preventing long-term issues, such as chronic venous insufficiency. As DVT is a prevalent and potentially serious condition, the demand for catheter-directed thrombolysis devices remains high in the market.

Breakup by End User:

Hospitals
Others

Hospitals represent the leading market segment

Hospitals serve as central hubs for medical care and are equipped with advanced facilities, skilled healthcare professionals, and specialized departments, making them ideal settings for performing catheter-directed thrombolysis procedures. The complexity and critical nature of vascular diseases and thrombotic disorders often require a multidisciplinary approach involving interventional radiologists, vascular surgeons, cardiologists, and other medical specialists available in a hospital environment. These medical professionals collaborate to diagnose and treat patients with conditions, including pulmonary embolism, deep vein thrombosis, peripheral arterial occlusions, and other vascular obstructions. Moreover, hospitals have access to state-of-the-art imaging technologies, such as fluoroscopy, ultrasound, and computed tomography (CT), which aid in precise catheter navigation and real-time visualization of the clot during the procedure. Additionally, hospitals maintain a comprehensive range of medical equipment and devices, including the latest catheter-directed thrombolysis technologies, to ensure optimal patient care.

Breakup by Region:

North America
- United States
- Canada
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (United States and Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Russia and the rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, Indonesia and rest of Asia-Pacific), Latin America (Brazil, Mexico and rest of Latin America) and the Middle East and Africa. According to the report, North America represents the leading market.

The market in North America is primarily being driven due to advanced healthcare infrastructure, a well-established medical device industry, and a high prevalence of vascular diseases in the region. The region's strong emphasis on healthcare research and innovation has led to the development of cutting-edge catheter-directed thrombolysis devices, further driving their adoption.

The market in Asia Pacific is witnessing an increase in the aging population, which is more susceptible to vascular conditions, further augmenting the demand for these devices. The presence of leading medical device manufacturers and ongoing research and development efforts also contribute to the growth of the market in the Asia Pacific. With a combination of a vast patient pool, improving healthcare facilities, and a focus on technological advancements, the Asia Pacific region is expected to maintain its dominant position in the catheter-directed thrombolysis devices market.

Competitive Landscape:

Companies in the market are heavily investing in research and development to improve the design, efficacy, and safety of their catheter-directed thrombolysis devices. They are focused on creating innovative technologies and drug delivery mechanisms to enhance the clot-dissolving process and minimize the risk of bleeding complications. Moreover, leading players are conducting clinical trials to gather evidence of safety and efficacy and obtaining regulatory approvals from health authorities to market their devices globally. These processes helped establish the credibility and compliance of their products. Additionally, several companies are providing training and educational programs to healthcare professionals to ensure they had the necessary skills and knowledge to use catheter-directed thrombolysis devices effectively and safely. To stay competitive, major companies are launching new catheter-directed thrombolysis devices or upgraded existing ones. These products were often designed to be more user-friendly, precise, and capable of achieving better patient outcomes.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

AngioDynamics, Inc.
Boston Scientific Corporation
Inari Medical, Inc.
iVascular, S.L.U
Medtronic Plc
Penumbra, Inc.
Straub Medical AG (Becton, Dickinson, and Company)
Teleflex Incorporated
Thrombolex Inc.

Key Questions Answered in This Report

1.How big is the catheter-directed thrombolysis devices market?
2.What is the future outlook of catheter-directed thrombolysis devices market?
3.What are the key factors driving the catheter-directed thrombolysis devices market?
4.Which region accounts for the largest catheter-directed thrombolysis devices market share?
5.Which are the leading companies in the global catheter-directed thrombolysis devices market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Catheter-Directed Thrombolysis Devices Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Delivery Mode

6.1 Directly Delivery to Blood Clot
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Positioning Medical Device at Clot Site
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Indication

7.1 Pulmonary Embolism (PE)
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Deep Vein Thrombosis (DVT)
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Stroke
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by End User

8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Others
- 8.2.1 Market Trends
- 8.2.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Europe
- 9.2.1 Germany
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 France
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 United Kingdom
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 Italy
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Spain
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Russia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Rest of Europe
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Asia-Pacific
- 9.3.1 China
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 India
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 Japan
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Australia
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 South Korea
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Indonesia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Rest of Asia-Pacific
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Rest of Latin America
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 AngioDynamics, Inc
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT
- 14.3.2 Boston Scientific Corporation
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT
- 14.3.3 Inari Medical, Inc.
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
- 14.3.4 iVascular, S.L.U
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
- 14.3.5 Medtronic Plc
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT
- 14.3.6 Penumbra, Inc.
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
- 14.3.7 Straub Medical AG (Becton, Dickinson and Company)
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT
- 14.3.8 Teleflex Incorporated
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
  - 14.3.8.4 SWOT
- 14.3.9 Thrombolex Inc.
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio

カテーテル指向性血栓溶解療法の市場レポート：送達モード、適応症、エンドユーザー、地域別、2025年～2033年

Catheter-Directed Thrombolysis Devices Market Report by Delivery Mode, Indication (Pulmonary Embolism, Deep Vein Thrombosis, Stroke, and Others), End User, and Region 2025-2033

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界のカテーテル指向性血栓溶解療法市場

第6章 市場内訳：送達モード別

第7章 市場内訳：適応症別

第8章 市場内訳：エンドユーザー別

第9章 市場内訳：地域別

第10章 SWOT分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 価格分析

第14章 競合情勢